The Patent Finder

Modulators of sperm hypermotility and uses thereof

Hydra Biosciences, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,394,840Modulators of sperm hypermotility and uses thereof
In force
 · High confidence
UsedRemaining
Hydra Biosciences, Inc.In forceHigh confidence
US 8,952,041Modulators of Sperm Hypermobility and Uses Thereof
Term ended
Term ended Jun 15, 2026 · High confidence
Hydra Biosciences, Inc.Term endedTerm ended Jun 15, 2026High confidence
US 9,732,050Modulators of Sperm Hypermotility and Uses Thereof
Term ended
Ended no later than Jun 15, 2026 · Medium confidence
Hydra Biosciences, Inc.Term endedEnded no later than Jun 15, 2026Medium confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Hydra Biosciences, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited